Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, NDC 55111-629-30
Published July 10, 2024 · Recall initiated: June 4, 2024
Summary
FDA records drug Class III recall D-0581-2024, published July 10, 2024 and initiated June 4, 2024. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Ongoing; Reported quantity: 13,752 bottles; Lot: Lot#: C2302598, Exp 2/29/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Related Substances
What to do
Voluntary: Firm initiated
Get an email if ESZOPICLONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ESZOPICLONE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- OH, MS
- UPC
- 0355111617013
- Lot
- Lot#: C2302598, Exp 2/29/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADodex Injectable (Cyanocobalamin Injection) USP, 1,000mcg/mL, 1mL multiple dose vial, Rx only, ManufacturedJuly 10, 2024
- FDADecitabine for Injection 50mg per vial, For intravenous infusion only Cytotoxic Agent, Sterile, Rx Only,July 10, 2024
- FDAMethylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, ManufacturedJuly 10, 2024
- FDAAllopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LAJuly 10, 2024
- FDALittle Moon Essentials, Clear Breeze Plus, Hand Sanitizer (Alcohol 65% v/v) Packaged as a) 2 FL OZ (60ML)July 10, 2024
- FDAEszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA,July 13, 2022
Questions about this recall
Was Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, NDC 55111-629-30 recalled?
Yes. FDA published recall D-0581-2024 on July 10, 2024. Reported hazard: Failed Impurities/Degradation Specifications: Related Substances
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ESZOPICLONE. UPC: 0355111617013.